ENDRA Life Sciences (NDRA) Assets Average (2017 - 2026)

ENDRA Life Sciences (NDRA) has 10 years of Assets Average data on file, last reported at $3.6 million in Q1 2026.

• Assets Average for Q1 2026 came in at $3.6 million, down 4.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.6 million (down 4.34% YoY), and the FY2025 annual result was $4.2 million, down 25.88% from the prior year.
• Assets Average grew to $3.6 million in Q1 2026 per NDRA's latest filing, from $2.9 million in the prior quarter.
• Over five years, Assets Average peaked at $13.8 million in Q3 2022 and troughed at $2.4 million in Q3 2025.
• A 5-year average of $7.4 million and a median of $7.8 million in 2024 frame the typical range for Assets Average.
• The sharpest annual moves came in 2024 and 2025: Assets Average advanced 11.72% in 2024, then plunged 74.65% in 2025.
• A 5-year view of Assets Average shows it stood at $10.8 million in 2022, then sank by 33.58% to $7.2 million in 2023, then fell by 10.63% to $6.4 million in 2024, then sank by 54.66% to $2.9 million in 2025, then climbed by 25.34% to $3.6 million in 2026.
• Business Quant data shows NDRA's Assets Average at $3.6 million in Q1 2026, $2.9 million in Q4 2025, and $2.4 million in Q3 2025.